Cargando…
Management of Coagulopathy in Bleeding Patients
Early recognition of coagulopathy is necessary for its prompt correction and successful management. Novel approaches, such as point-of-care testing (POC) and administration of coagulation factor concentrates (CFCs), aim to tailor the haemostatic therapy to each patient and thus reduce the risks of o...
Autores principales: | Hofer, Stefan, Schlimp, Christoph J., Casu, Sebastian, Grouzi, Elisavet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745606/ https://www.ncbi.nlm.nih.gov/pubmed/35011742 http://dx.doi.org/10.3390/jcm11010001 |
Ejemplares similares
-
Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014) -
COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020) -
Management of bleeding and coagulopathy following major trauma: an updated European guideline
por: Spahn, Donat R, et al.
Publicado: (2013) -
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition
por: Rossaint, Rolf, et al.
Publicado: (2023) -
Coagulopathies in Intensive Care Medicine: Balancing Act between Thrombosis and Bleeding
por: Neuenfeldt, Friederike S., et al.
Publicado: (2021)